Co-Hosted by

Contact



Highlights and Feedback:
Paws for a Cure Research Symposium 2018

Over 200 Pediatric oncologists, veterinary oncologists, translational research scientists in academia and in industry united in Boston this November 12-13 to learn about comparative and translational approaches to accelerate development of new and better medicines for the treatment of cancer, particularly devastating shared childhood and canine cancers.

Event Testimonials:

• For a meeting of this kind - it help a balance of science, policy and problem solving good job

• Diverse subject matter, short duration of talks, attendees representing different sectors (industry, academia, pharm etc), cartoon documentation of sessions, frequent short breaks increasing time to meet other attendees and make new contacts.

• Excellent line of speakers and engagement with many more researchers during coffee breaks.

• The short talk format allowed me to remain engaged with the material throughout the conference.

• The presentations were uniformly of high quality. Also, many of the speakers were quite prominent in their fields.

• I enjoyed the relatively small size of the meeting, making it easier to network and meet new people. I also enjoyed the discourse between the group after the talks. 

• I liked how a lot of the doctors explained what they were talking about. Because of this I understood a lot of their presentations. 

• The high caliber of speakers and attendees and the open communication and sharing of information. All the stakeholder groups were well represented. 

• Great speakers, good amount of time for networking (break times and lunches allowed some conversations), very nice venue. Great to have industry (big and small), survivors, vet and human oncology types, government, etc. A really good mix. 

• Sharing of expertise - which lead to ideas to further research collaborations. 

• The information presented was interesting and relevant. I enjoyed the different perspectives presented. Also, 15 minute lectures were perfect in length, and there were adequate breaks. 

• Bringing together experts from disparate fields to discuss common goals of care. hearing what experts are doing in the canine field to advance oncology care and where collaborations might expand. 

• Content was broad, talks were concise and covered a wide range of topics, panel sessions for discussion were built in. 

• The mix of backgrounds for the attendees led to excellent discussion and intellectual curiosity. 

• Really high quality participants on both human and animal sides.

• Chance to meet and interact with other scientists working in the same field (canine cancer).

• I loved that you were able to have a number of veterinary and human oncologists present and take part in the discussion. Also it was fantastic to have someone from the FDA come and present. 

• Hearing from cancer survivors, particularly Mary and the pediatric oncologists. I also liked that there were sponsors other than pharmaceutical companies, like PETCO. 

• That it allowed access to key opinion leaders across the spectrum; that leading organizations in cancer research were in support and present; the emphasis on the patient perspective.

• I loved this event! It was very interesting and useful as a veterinary oncology resident. More residents should be given the opportunity to attend.

• It is becoming (has become) the premier canine oncology meeting in the country.

 

About This Event

Advancing research in pediatric cancer treatments has unique challenges, and progress toward better medicines and a cure has been limited. Intriguingly, BOTH children and our canine companions spontaneously develop a number of cancers with remarkable similarities, including osteosarcoma, certain brain/CNS cancers, lymphoma and leukemia. Speakers, panelists and participants will discuss challenges and progress in accelerating cancer drug development using comparative approaches, including:

  • The state of the art in comparative and novel translational cancer research.
  • Ongoing preclinical, translational and clinical projects leveraging the canine patient model.
  • The most promising prospects for future scientific exploration, collaboration and funding.
  • Life journey presentations by childhood cancer survivors and advocates.

In addition to cutting edge scientific content, the Symposium agenda will include poignant presentations from patient advocates and feature prominent keynote speakers.

If you have questions about this event, contact: Info@pawsforacuresymposium.com

If your company would like to financially support the 2018 Paws for a Cure Research Symposium, please contact: Info@pawsforacuresymposium.com

Who should attend: Pediatric oncologists, veterinary oncologists, translational research scientists in academia and in industry; pharma and biotech professionals in preclinical research, drug development, oncology and animal health; nonprofit and other funders interested in learning about comparative and translational approaches to accelerate development of new and better medicines for the treatment of cancer, particularly devastating shared childhood and canine cancers.


Title Sponsors

In Partnership with

Contributing Sponsor

Sponsors

Contact